Ended Therapeutic confirmatory (Phase III) Thyroidectomy is a common operation. Transient postoperative hypocalcemia is the main complication, resulting in clinical discomfort for patients, longer hospital stays and increased perioperative cost. Cholecalciferol is used to supplement vitamin D deficiency. We suppose that systematic pre-operative supplementation with cholecalciferol would allow a faster and more appropriate response to post-operative hypocalcemia

Study of total post-thyroidectomy hypocalcemia after preoperative cholecalciferol supplementation

EU CTIS ID: 2024-516793-30-00

What this study is testing

Assessment of the effect of pre-operative cholecalciferol supplementation on the occurrence of post-operative hypocalcemia aftertotal thyroidectomy

  • Therapeutic confirmatory (Phase III)

A plain-language read of the study's public EU CTIS listing. The study team confirms the details.

Who can take part

You may be able to join if

  • Patient ≥ 18 years old
  • Patient shall be operated on for a total thyroidectomy in one time for any indication
  • Written informed consent (IC) obtained
  • Patients with affiliation to the social security system

You likely can't join if

  • Medical history of : thyroid or parathyroid surgery, Hyperparathyroidism , granulomatosis flare-up
  • Pregnant women
  • Vulnerable populations (guardianship or trusteeship)
  • Persons deprived of their liberty by court or administrative decision
  • Chronic kidney disease grade ≥4
  • 25OHD supplementation within last 3 months before surgery
See the full eligibility criteria
Who can join
  • Patient ≥ 18 years old
  • Patient shall be operated on for a total thyroidectomy in one time for any indication
  • Written informed consent (IC) obtained
  • Patients with affiliation to the social security system
What rules you out
  • Medical history of : thyroid or parathyroid surgery, Hyperparathyroidism , granulomatosis flare-up
  • Pregnant women
  • Vulnerable populations (guardianship or trusteeship)
  • Persons deprived of their liberty by court or administrative decision
  • Chronic kidney disease grade ≥4
  • 25OHD supplementation within last 3 months before surgery
  • Malabsorption syndrome
  • Known hypersensitivity to vitamin D
  • Allergies to one of the components of the fruit juice
  • Medical history of calcic lithiasis
  • Hypocalcemia, hypercalcemia/ hypercalciuria, or symptom of Hypocalcemia, hypercalcemia/ hypercalciuria, not due to thyroid pathologies
  • Severe liver failure

The study team makes the final eligibility decision.

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.